Page last updated: 2024-08-17

quinoxalines and Vomiting

quinoxalines has been researched along with Vomiting in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's4 (44.44)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrios, M; Cicero, A; Cristóbal, M; Jiménez-Ruiz, CA; Mayayo, M; Peña, S; Perera, L1
Faessel, HM; Rollema, H; Williams, KE1
Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M1
Dodds, WJ; Lang, IM; Sarna, SK1
Fukuda, H; Furukawa, N; Hatano, M; Koga, T1
Lang, IM; Sarna, SK; Shaker, R1
Fukuda, H; Furukawa, N; Hatano, M1
Fink-Jensen, A; Hansen, JB; Honoré, T; Jacobsen, P; Judge, ME; Olney, J; Turski, L1
Clark, GM; Coltman, CA; Hersh, M; Kuhn, JG; Melink, T; Von Hoff, DD; Weiss, GR1

Trials

1 trial(s) available for quinoxalines and Vomiting

ArticleYear
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting

2006

Other Studies

8 other study(ies) available for quinoxalines and Vomiting

ArticleYear
Increasing the dose of varenicline in patients who do not respond to the standard dose.
    Mayo Clinic proceedings, 2013, Volume: 88, Issue:12

    Topics: Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Vomiting

2013
Varenicline overdose in a teenager--a clinical pharmacology perspective.
    Clinical toxicology (Philadelphia, Pa.), 2009, Volume: 47, Issue:6

    Topics: Adolescent; Benzazepines; Drug Overdose; Humans; Nausea; Poisoning; Quinoxalines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Varenicline; Vomiting

2009
Pharyngeal, esophageal, and proximal gastric responses associated with vomiting.
    The American journal of physiology, 1993, Volume: 265, Issue:5 Pt 1

    Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Brimonidine Tartrate; Dogs; Electromyography; Esophagus; Female; Intestine, Small; Male; Models, Biological; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Nerve Block; Pharynx; Quinoxalines; Stomach; Vagus Nerve; Vomiting

1993
Non-N-methyl-D-aspartate receptors may mediate the transmission of emetic signals between visceral vagal afferents and the solitary nucleus in dogs.
    Neuroscience letters, 1998, Dec-11, Volume: 258, Issue:1

    Topics: Anesthesia; Animals; Decerebrate State; Dizocilpine Maleate; Dogs; Electric Stimulation; Excitatory Amino Acid Antagonists; Lingual Nerve; Phrenic Nerve; Quinoxalines; Reaction Time; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Salivation; Solitary Nucleus; Synaptic Transmission; Vagus Nerve; Vomiting

1998
Gastrointestinal motor and myoelectric correlates of motion sickness.
    The American journal of physiology, 1999, Volume: 277, Issue:3

    Topics: Animals; Atropine Derivatives; Brimonidine Tartrate; Cats; Copper Sulfate; Digestive System; Female; Gastrointestinal Motility; Male; Motion Sickness; Myoelectric Complex, Migrating; Quinoxalines; Salivation; Vagotomy; Vomiting

1999
Glutaminergic vagal afferents may mediate both retching and gastric adaptive relaxation in dogs.
    Autonomic neuroscience : basic & clinical, 2001, Oct-08, Volume: 93, Issue:1-2

    Topics: Action Potentials; Animals; Catheterization; Dizocilpine Maleate; Dogs; Esophagus; Excitatory Amino Acid Antagonists; Ganglionic Blockers; Glutamic Acid; Hexamethonium; Neurons, Afferent; Quinoxalines; Reflex; Solitary Nucleus; Stomach; Vagotomy; Vagus Nerve; Vomiting

2001
Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
    Neuroscience letters, 1992, Mar-30, Volume: 137, Issue:2

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Exploratory Behavior; Ferrets; Imidazoles; Male; Ondansetron; Quinoxalines; Receptors, Amino Acid; Receptors, Cell Surface; Serotonin Antagonists; Vomiting

1992
Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:5

    Topics: Adult; Aged; Drug Evaluation; Echinomycin; Female; Humans; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Quinoxalines; Thrombocytopenia; Vomiting

1989